Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
BMJ Case Reports
|
June 4, 2017
Fabry heterozygote mimicking multiple sclerosis
Wai Yan Yau, Marzena J Fabis-Pedrini, Allan G Kermode
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
November 7, 2015
Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment
Marzena J Fabis-Pedrini, Wen Xu, Jason Burton, et al.
Journal of Neuroimmunology
|
September 25, 2018
Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia
Marzena J Fabis-Pedrini, Christine Bundell, Chee-Keong Wee, et al.
Frontiers in Immunology
|
May 15, 2026
Immature CD10<sup>low</sup> blood neutrophils are enriched in people with multiple sclerosis
Luke W Garratt, Alice A White, Craig Schofield, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 21, 2015
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females
Marzena J Fabis Pedrini, Alexandra Seewann, Kirsten A Bennett, et al.
Multiple Sclerosis and Related Disorders
|
June 24, 2025
Design, acceptability, and measured outcomes of music interventions for walking in persons with multiple sclerosis: A scoping review
Jocelyn Tan, Ann Maree Vallence, Hannah Fenwick, et al.
International Journal of Molecular Sciences
|
June 16, 2017
Evolving Identification of Blood Cells Associated with Clinically Isolated Syndrome: Importance of Time since Clinical Presentation and Diagnostic MRI
Stephanie Trend, Anderson P Jones, Sian Geldenhuys, et al.
Clinical & Translational Immunology
|
July 11, 2017
Altered regulatory T-cell fractions and Helios expression in clinically isolated syndrome: clues to the development of multiple sclerosis
Anderson P Jones, Stephanie Trend, Scott N Byrne, et al.
JMIR Research Protocols
|
October 19, 2021
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
Vicki E Maltby, Rodney A Lea, Mastura Monif, et al.
Brain and Behavior
|
January 27, 2022
Changes in serum neurofilament light chain levels following narrowband ultraviolet B phototherapy in clinically isolated syndrome
Marzena J Fabis-Pedrini, Jens Kuhle, Katherine M A Roberts, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
BMJ Case Reports
|
June 4, 2017
Fabry heterozygote mimicking multiple sclerosis
Wai Yan Yau, Marzena J Fabis-Pedrini, Allan G Kermode
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
November 7, 2015
Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment
Marzena J Fabis-Pedrini, Wen Xu, Jason Burton, et al.
Journal of Neuroimmunology
|
September 25, 2018
Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia
Marzena J Fabis-Pedrini, Christine Bundell, Chee-Keong Wee, et al.
Frontiers in Immunology
|
May 15, 2026
Immature CD10<sup>low</sup> blood neutrophils are enriched in people with multiple sclerosis
Luke W Garratt, Alice A White, Craig Schofield, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 21, 2015
Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females
Marzena J Fabis Pedrini, Alexandra Seewann, Kirsten A Bennett, et al.
Multiple Sclerosis and Related Disorders
|
June 24, 2025
Design, acceptability, and measured outcomes of music interventions for walking in persons with multiple sclerosis: A scoping review
Jocelyn Tan, Ann Maree Vallence, Hannah Fenwick, et al.
International Journal of Molecular Sciences
|
June 16, 2017
Evolving Identification of Blood Cells Associated with Clinically Isolated Syndrome: Importance of Time since Clinical Presentation and Diagnostic MRI
Stephanie Trend, Anderson P Jones, Sian Geldenhuys, et al.
Clinical & Translational Immunology
|
July 11, 2017
Altered regulatory T-cell fractions and Helios expression in clinically isolated syndrome: clues to the development of multiple sclerosis
Anderson P Jones, Stephanie Trend, Scott N Byrne, et al.
JMIR Research Protocols
|
October 19, 2021
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
Vicki E Maltby, Rodney A Lea, Mastura Monif, et al.
Brain and Behavior
|
January 27, 2022
Changes in serum neurofilament light chain levels following narrowband ultraviolet B phototherapy in clinically isolated syndrome
Marzena J Fabis-Pedrini, Jens Kuhle, Katherine M A Roberts, et al.
Page
of 3